ANTIHYPERLIPIDEMIC EFFECT OF PANCHATIKTA GHANA AND SHUDDHA GUGGULU: AN EXPERIMENTAL STUDY
DOI:
https://doi.org/10.70066/jahm.v1i1.100Keywords:
Hyperlipidemia, Medoroga, Albino rats, Panchatikta Ghana, Shuddha Guggulu (purified Guggulu)Abstract
Hyperlipidemia is emerging as major health problem in the modern era. Hyperlipidemia leads to coronary artery disease, myocardial infarction and cerebrovascular accidents (CVA).Coronary heart disease (CHD) is the number one killer among the diseases and it accounts for 37% of adult deaths in the US every year. Nikolai Anichkov in 1912 discovered the role of cholesterol in CHD, currently the world’s most deadly disease. An experimental study was done on albino rats to evaluate the effect of Panchatikta Ghana (combination of Adhatoda vesica, Azadirachta indica, Tinospora cordifolia, Solanum xanthocarpum and Trichosanthes dioica) and Shuddha Guggulu (Commiphora mukul) in hyperlipidemia induced albino rats. The study showed that Shuddha Guggulu has cardioprotective activity as it has increased the HDL Level and this drug also reduced the serum triglycerides to significant level and thus gave antihypertriglyceridaemic activity too. Both of the drugs were free from any side effects. Shuddha Guggulu was having better effect in reducing the body weight of the albino rats than Panchatikta Ghana.
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 UMESH KUMAR SAPRA
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.
